This study developed, optimized, characterized, and evaluated bioadhesive, hot-melt extruded (HME), extended-release ocular inserts containing ciprofloxacin hydrochloride (CIP-HCL) to improve the therapeutic outcomes of ocular bacterial infections. The inserts were fabricated with FDA-approved biocompatible, biodegradable, and bioadhesive polymers that were tuned in different ratios to achieve a sustained release profile.
During Friday's trading session, Aarti Drugs stock has slumped by nearly 5% after clocking the lower circuit of Rs2781.75 per piece on Sensex. The performance was swayed after the government imposed anti-dumping duty on Ciprofloxacin Hydrochloride imports from China.
The Union commerce ministry is contemplating to impose anti-dumping duty on Chinese active pharmaceutical ingredient (API) ciprofloxacin hydrochloride with an aim to protect domestic players from cheap imports.
Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Manufactured and Distributed as Altaire Labeled Products
Dr Reddy's Laboratories, a Rs. 14,800 crore plus pharma giant from Hyderabad, has posted strong growth in bottomline during the year ended March 2019 despite pressure on top line. The consolidated net profit went up sharply by 106 per cent to Rs. 1,950 crore from Rs. 947 crore and its basic earnings per share improved to Rs. 117.53 from Rs. 57.08 in the last year. Though the margins improved, the DRL scrip received setback after the announcement of financial working and declined sharply by over 5.8 per cent to Rs. 2,588 on BSE on May 20, 2019 with market capitalization of Rs. 44,194 crore. The scrip touched to its yearly high level at Rs. 2,965 on May 2, 2019 as it started moving from yearly lowest level of Rs. 1,888 on May 21, 2018
Yiling Pharm’s Generic Ciprofloxacin HCL Receives Approval In US
The case, which began in 2000 in California state court, centers on a series of settlements in the late 1990s under which Bayer allegedly paid Barr Pharmaceuticals, since bought by Teva, $398 million not to market Cipro's generic version. Bayer had earlier sued Barr claiming that generic Cipro would infringe a Bayer patent. reut.rs/2jkzNtL
The main grievance of the company was that the data considered by NPPA was pertaining to September, 2013 while the notification was issued by them in September, 2014, which is one year later while the period is six months as per DPCO, 2013. Further, the company stated that they did not avail any WPI. However, WPI was due to for the year 2012 as well as 2013. Company representative further referred the Bombay High Court Order dated 14.1.2005 in WP No.6135/03 vacated the interim orders, if any. The company further referred to the Bombay High Court Order dated 15.3.2005 vide which the ad interim order dated 20.3.2003 stood revived.
Anuh Pharma LTD fails EDQM Inspection
I have long had severe reservations about quinolone antibiotics, like Levaquin and Cipro. I have had these concerns since I conducted clinical trials to test new antibiotics (including a variety of quinolones) before they went to market. Now I have further concerns about them because of their overuse as an alternative to busy physicians trying to puzzle out what’s wrong with the patient, and because practice “guidelines” promote their overuse.